Nouvelle déclaration d'incident
No de la demande: 2014-0792
Numéro de référence du titulaire d'homologation: 130139288
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G5L3
Incident chez un animal domestique
Pays: UNITED STATES
État: INDIANA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2724-777-270
Nom du produit: Adams Carpet Powder With Linalool and Nylar
Poudre
Oui
Inconnu
Site: Res. - Out Home / Rés - à l'ext.maison
Non
Propriétaire de l'animal
Dog / Chien
Border Collie
1
Homme
0.31
15.0
lbs
Cutanée
>3 days <=1 wk / >3 jours <=1 sem
Unknown / Inconnu
Système
Persisted until death
Oui
Inconnu
Mort
Contact treat.area/Contact surf. traitée
(p.ex. description des symptômes tels que la fréquence et la gravité
On the evening of October 1, 2013, shortly after being introduced to the treated area, the owner noticed that the puppy was polydipsic. On October 2, 2013 the owner took the puppy to the veterinarian, where a physical exam was done, but no diagnostics were done; the puppy then went back home. On October 3, 2013 the puppy was adopted by someone else, who informed the owner that the puppy was lethargic that evening. On October 4, 2013 the owner contacted the Animal Product Safety Service (APSS) to obtain help. The APSS veterinarian said that the severity of signs the puppy was experiencing would not be expected. The APSS veterinarian recommended that the owner take the puppy to the veterinarian and have the veterinarian call for information.
Mort
The APSS veterinarian stated that the substance was not considered to be related to causing the clinical situation. On October 7, 2013 an APSS assistant called the owner to update the case. The owner stated that on October 5, 2013 the puppy was taken to the veterinarian, where he was diagnosed with Parvovirus; that day, the puppy died. The APSS veterinarian stated that Parvovirus was considered to have a high likelihood of causing the clinical situation. A necropsy was not available. Extra Label Use: Indoor product used outdoors and area not vacuumed.
Propriétaire de l'animal
Dog / Chien
Border Collie
1
Homme
0.31
15.0
lbs
Cutanée
>3 days <=1 wk / >3 jours <=1 sem
Unknown / Inconnu
Système
Persisted until death
Oui
Inconnu
Mort
Contact treat.area/Contact surf. traitée
(p.ex. description des symptômes tels que la fréquence et la gravité
On the evening of October 1, 2013, shortly after being introduced to the treated area, the owner noticed that the puppy was polydipsic. On October 2, 2013 the owner took the puppy to the veterinarian, where a physical exam was done, but no diagnostics were done; the puppy then went back home. On October 3, 2013 the owner noticed that the puppy was lethargic. On October 4, 2013 the owner noticed that the puppy was inappetent, vomiting, and weak; at that time, the owner started giving the puppy an oral electrolyte solution between episodes of vomiting and giving the puppy a liquid Bismuth Subsalicylate product to treat the puppy. Later that evening the owner contacted the Animal Product Safety Service (APSS) to obtain help. The APSS veterinarian stated that if the product was ingested, self-limiting gastrointestinal (GI) upset could be seen. The APSS veterinarian said that the severity of signs the puppy was experiencing would not be expected. Regarding the liquid Bismuth Subsalicylate product, the APSS veterinarian stated that if enough was given, GI ulcers or liver effects could be seen from the aspirin in the product. The APSS veterinarian recommended that the owner take the puppy to the veterinarian, have the veterinarian call for information, and discontinue giving the liquid Bismuth Subsalicylate product.
Mort
The APSS veterinarian stated that the carpet powder product and the liquid Bismuth Subsalicylate product were not considered to be related to causing the clinical situation. On October 7, 2013 an APSS assistant called the owner to update the case. The owner stated that on October 5, 2013 the puppy was taken to the veterinarian, where he was diagnosed with Parvovirus; that day, the puppy died. The APSS veterinarian stated that Parvovirus was considered to have a high likelihood of causing the clinical situation. A necropsy was not available. Extra Label Use: Indoor product used outdoors and area not vacuumed.
Propriétaire de l'animal
Dog / Chien
Border Collie
1
Homme
0.31
15.0
lbs
Cutanée
>3 days <=1 wk / >3 jours <=1 sem
Unknown / Inconnu
Système
Persisted until death
Oui
Inconnu
Mort
Contact treat.area/Contact surf. traitée
(p.ex. description des symptômes tels que la fréquence et la gravité
On the evening of October 1, 2013, shortly after being introduced to the treated area, the owner noticed that the puppy was polydipsic. On October 2, 2013 the owner took the puppy to the veterinarian, where a physical exam was done, but no diagnostics were done; the puppy then went back home. On October 3, 2013 the owner noticed that the puppy was lethargic. On October 4, 2013 the owner noticed that the puppy was inappetent and vomiting; at that time, the owner started giving the puppy an oral electrolyte solution between episodes of vomiting and giving the puppy a liquid Bismuth Subsalicylate product to treat the puppy. That evening the owner noticed that the puppy was very weak and unable to get up. A short time later that evening the owner contacted the Animal Product Safety Service (APSS) to obtain help. The APSS veterinarian stated that if the product was ingested, self-limiting gastrointestinal (GI) upset could be seen. The APSS veterinarian said that the severity of signs the puppy was experiencing would not be expected. Regarding the liquid Bismuth Subsalicylate product, the APSS veterinarian stated that if enough was given, GI ulcers or liver effects could be seen from the aspirin in the product. The APSS veterinarian recommended that the owner take the puppy to the veterinarian, have the veterinarian call for information, and discontinue giving the liquid Bismuth Subsalicylate product.
Mort
The APSS veterinarian stated that the carpet powder product and the liquid Bismuth Subsalicylate product were not considered to be related to causing the clinical situation. On October 7, 2013 an APSS assistant called the owner to update the case. The owner stated that on October 5, 2013 the puppy was taken to the veterinarian, where he was diagnosed with Parvovirus; that day, the puppy died. The APSS veterinarian stated that Parvovirus was considered to have a high likelihood of causing the clinical situation. A necropsy was not available. Extra Label Use: Indoor product used outdoors and area not vacuumed.
Propriétaire de l'animal
Dog / Chien
Border Collie
1
Homme
0.31
15.0
lbs
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Non
Non
Mort
Contact treat.area/Contact surf. traitée
(p.ex. description des symptômes tels que la fréquence et la gravité
On the evening of October 1, 2013, shortly after being introduced to the treated area, the owner noticed that the puppy was symptomatic. Early on the morning of October 2, 2013 the owner observed that the puppy had died. On October 4, 2013 the owner contacted the Animal Product Safety Service (APSS) to obtain help. The APSS veterinarian stated that the risk if the product was ingested, self-limiting gastrointestinal (GI) upset could be seen. The APSS veterinarian said that the severity of signs the puppy experienced would not be expected. A necropsy was not available.
Mort
The APSS veterinarian stated that the substance was considered to have a doubtful likelihood of causing the clinical situation. Puppies were all diagnosed with Parvovirus. Extra Label Use: Indoor product used outdoors and area not vacuumed.